| ²é¿´: 1976 | »Ø¸´: 8 | |||
| ±¾Ìû²úÉú 1 ¸ö LS-EPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
majunjie3612½ð³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
BMS-777607ÁÙ´²Ñо¿½øÕ¹
|
||
|
ÏÖÔÚÕýÔÚ²éBMS-777607Õâ¸ö»¯ºÏÎïÏÖÔÚµÄÁÙ´²ÊÔÑé½øÕ¹£¬×Ô¼º²éÁËһЩ×ÊÁÏ£¬¸Ð¾õ²»È«¶øÇÒÓÐЩÂÒ£¬ÓÐÄÄλÄܰïæ²éһϣ¬»òÕß×îºÃÄܸæËßÎÒÓ¦¸ÃÔõô²éÄܹ»µÃµ½µÄ×ÊÁϱȽÏÈ«¡£ °ÝÍдó¼ÒÁË£¬Ï£ÍûÖªµÀµÄ°ï°ï棡 ÔÙ´Ëһһл¹ýÀ² |
» ²ÂÄãϲ»¶
346Çóµ÷¼Á[0856]
ÒѾÓÐ7È˻ظ´
һ־Ըɽ´ó07»¯Ñ§ 332·Ö ËÄÁù¼¶Òѹý ±¾¿ÆÉ½¶«Ë«·Ç Çóµ÷¼Á£¡
ÒѾÓÐ3È˻ظ´
310Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
»úеר˶299Çóµ÷¼ÁÖÁ²ÄÁÏ
ÒѾÓÐ4È˻ظ´
070300»¯Ñ§319Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
08¹¤¿Æ 320×Ü·Ö Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸Ìì½ò´óѧ»¯Ñ§¹¤ÒÕרҵ£¨081702£©315·ÖÇóµ÷¼Á
ÒѾÓÐ12È˻ظ´
307Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
baiyuefei
°æÖ÷ (ÎÄѧ̩¶·)
·çÑ©
- LS-EPI: 1647
- Ó¦Öú: 4642 (¸±½ÌÊÚ)
- ¹ó±ö: 46.969
- ½ð±Ò: 658102
- É¢½ð: 11616
- ºì»¨: 995
- ɳ·¢: 81
- Ìû×Ó: 69424
- ÔÚÏß: 13328.1Сʱ
- ³æºÅ: 676696
- ×¢²á: 2008-12-18
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
- ¹ÜϽ: Óлú½»Á÷
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
majunjie3612: ½ð±Ò+5, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ·Ç³£¸Ðл£¡ 2012-05-09 23:32:56
li273273: ½ð±Ò+1, ¼ìË÷EPI+1, ¸ÐлӦÖú£¡ 2012-05-11 22:29:57
black467: ¼ìË÷EPI-1, EPI°ä·¢´íÎó 2012-07-18 21:25:13
black467: ¼ìË÷EPI+1, sorry ÊÇ¶ÔµÄ 2012-07-18 21:25:40
majunjie3612: ½ð±Ò+5, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ·Ç³£¸Ðл£¡ 2012-05-09 23:32:56
li273273: ½ð±Ò+1, ¼ìË÷EPI+1, ¸ÐлӦÖú£¡ 2012-05-11 22:29:57
black467: ¼ìË÷EPI-1, EPI°ä·¢´íÎó 2012-07-18 21:25:13
black467: ¼ìË÷EPI+1, sorry ÊÇ¶ÔµÄ 2012-07-18 21:25:40
Phase 2 ½áÊøÁË![]() ![]() ¡£¡£¡£¡£¡£¡£¡£ |
7Â¥2012-05-09 11:44:25
baiyuefei
°æÖ÷ (ÎÄѧ̩¶·)
·çÑ©
- LS-EPI: 1647
- Ó¦Öú: 4642 (¸±½ÌÊÚ)
- ¹ó±ö: 46.969
- ½ð±Ò: 658102
- É¢½ð: 11616
- ºì»¨: 995
- ɳ·¢: 81
- Ìû×Ó: 69424
- ÔÚÏß: 13328.1Сʱ
- ³æºÅ: 676696
- ×¢²á: 2008-12-18
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
- ¹ÜϽ: Óлú½»Á÷
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
|
¸Ã²úÆ·ÔÚÄÇÑз¢µÄ¾ÍÈ¥ÄǸö¹ú¼ÒµÄʳƷҩƷ¼à¶½¹ÜÀí¾Ö²éѯ°É¡£ ÔÙ²éϸõ¥Î»µÄ·¢±íµÄÎÄÕÂÓëרÀû£¨¿ÉÒÔÓÃCA¼ìË÷Ï£© http://www.google.com.hk/search? ... 0...0.0.r-yMgTcJ2vo ¹©²Î¿¼¡£ |
2Â¥2012-05-06 10:54:17
baiyuefei
°æÖ÷ (ÎÄѧ̩¶·)
·çÑ©
- LS-EPI: 1647
- Ó¦Öú: 4642 (¸±½ÌÊÚ)
- ¹ó±ö: 46.969
- ½ð±Ò: 658102
- É¢½ð: 11616
- ºì»¨: 995
- ɳ·¢: 81
- Ìû×Ó: 69424
- ÔÚÏß: 13328.1Сʱ
- ³æºÅ: 676696
- ×¢²á: 2008-12-18
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
- ¹ÜϽ: Óлú½»Á÷
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
|
ÕâÊÇCAÉϹØÓÚBMS-777607µÄËùÓÐÎÄÏ×£¬¹²11ƪ£¬Ó¦¸ÃÊDZȽÏÈ«µÄÁË£¬×Ô¼ºÑо¿°É http://g.zhubajie.com/urllink.php?id=12323690hf2z53rmie8rhtae |
3Â¥2012-05-08 15:17:22
wshzh2001
ÖÁ×ðľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 11919.3
- ºì»¨: 1
- Ìû×Ó: 389
- ÔÚÏß: 70.7Сʱ
- ³æºÅ: 106134
- ×¢²á: 2005-11-16
- ÐÔ±ð: MM
- רҵ: ϸ°ûËÀÍö
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï
black467: ½ð±Ò+2, ¸Ðл½»Á÷ »¶Ó³£À´ 2012-07-18 21:26:41
black467: ½ð±Ò+2, ¸Ðл½»Á÷ »¶Ó³£À´ 2012-07-18 21:26:41
|
ÒѾ½áÊøÁË http://www.clinicaltrials.gov/ct ... S-777607&rank=1 ultiple Ascending Dose Study of BMS-777607 in Subjects With Advanced or Metastatic Solid Tumors This study has been completed. First Received on January 18, 2008. Last Updated on January 24, 2011 History of Changes Sponsor: Bristol-Myers Squibb Information provided by: Bristol-Myers Squibb ClinicalTrials.gov Identifier: NCT00605618 |
4Â¥2012-05-08 15:23:51













»Ø¸´´ËÂ¥
10